- Product details
- Data
- FAQ
- Related videos
Human Residual DNA Fragment (qPCR) Detection Kit
Product Introduction
Residual host cell DNA may carry tumor- or virus-related genes, posing potential risks, and drug regulatory authorities worldwide have imposed strict limits on its residual level. In May 2022, China's National Medical Products Administration (NMPA) issued the Technical Guidelines for Pharmaceutical Research and Evaluation of In-vivo Gene Therapy Products (Trial), clearly stating that "Control of residual DNA residue and fragment size is required. DNA residue should be kept below 10 ng per dose where possible, and residual DNA fragment size should be maintained under 200 bp." Pharmacopoeia of each country has also introduced several classic methods for host cell residual DNA detection, with real-time quantitative polymerase chain reaction (qPCR) currently being the optimal approach.
Series of residual DNA fragment analysis kits independently developed by Junyan Bioscitech can rapidly and specifically detect the size distribution of residual DNA fragment from multiple host cells (Human, Hela, 293 series including HEK293, 293T, etc.). The fragment distribution intervals include: < 100 bp, 100 - 200 bp, 200 - 500 bp, and > 500 bp. This kit is used in conjunction with our host residual DNA sample pretreatment kit of our company.
Advantages and Features
Low concentration repeatability CV value < 20%
Medium and high concentration repeatability CV value < 15%.
Performance Indicators
Follow us
Sales: +86 15234188795/18701864343
Tech : +86 19503412257
E-mail: sales@junyanbios.cn
Add: Building D, No. 13 Building, Liandong U Valley Taiyuan Science and Technology Innovation Center, No. 100 Tanghuai Road, Xiaodian District, Taiyuan City, Shanxi Province
Copyright © 2025-2026 All Rights Reserved. :晋ICP备2024052786号-2